A team of researchers from Peking University has published a pair of papers on a new iodine technique that can boost perovskite solar cell efficiency to 24%. This is because perovskite solar cells ...

Cancer Prevention Research publishes articles that focus on cancer prevention, preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis ...

SCLC incidence decreased by 3% annually from 2000 to 2020, attributed to reduced smoking rates and smoking-related policies. Survival rates for SCLC have shown only minor improvements despite ...

Henlius' commitment to stringent quality standards has been instrumental in achieving EC approval for serplulimab. In 2023, Henlius' manufacturing facilities and production lines of serplulimab ...

College of Physics and Electronic Information, Anhui Province Key Laboratory for Control and Applications of Optoelectronic Information Materials, Key Laboratory of Functional Molecular Solids, Anhui ...

(2696.HK) announced that its anti-PD-1 mAb, HANSIZHUANG (serplulimab, marketed as Hetronifly ® in Europe), has been officially approved by the European Commission (EC) for use in combination with ...

There are many great electric cars for sale in 2025, but most of them are larger vehicles that command higher prices. Small electric cars remain rare in the USA, whereas they’re thriving in ...

In patients with extensive-stage small-cell lung cancer (ES-SCLC), the first-line use of tislelizumab combined with chemotherapy has shown significant efficacy. However, with the widespread use of ...

Lung cancer is a form of cancer wherein abnormal cells start to grow in the lungs in an uncontrolled way. According to World Cancer Research Fund, there were nearly 2.4 million new cases of lung ...

Novel therapies targeting molecular pathways, including DLL3 and PARP inhibitors, show promise in improving SCLC survival outcomes. Tarlatamab, a DLL3-targeting bispecific T-cell engager ...